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Abstract
Introduction: Total hip replacement is one of the most commonly performed major orthopaedic operations. Goal-
directed therapy (GDT) using haemodynamic monitoring has previously demonstrated outcome benefits in high-
risk surgical patients under general anaesthesia. GDT has never been formally assessed during regional anaesthesia.
Methods: Patients undergoing total hip replacement while under regional anaesthesia were randomised to either
the control group (CTRL) or the protocol group (GDT). Patients in the GDT group, in addition to standard
monitoring, were connected to the FloTrac sensor/Vigileo monitor haemodynamic monitoring system, and a GDT
protocol was used to maximise the stroke volume and target the oxygen delivery index to > 600 mL/minute/m
2.
Results: Patients randomised to the GDT group were given a greater volume of intravenous fluids during the
intraoperative period (means ± standard deviation (SD): 6,032 ± 1,388 mL vs. 2,635 ± 346 mL; P < 0.0001), and
more of the GDT patients received dobutamine (0 of 20 CTRL patients vs. 11 of 20 GDT patients; P < 0.0003). The
GDT patients also received more blood transfused during the intraoperative period (means ± SD: 595 ± 316 mL vs.
0±0m L ;P < 0.0001), although the CTRL group received greater volumes of blood replacement postoperatively
(CTRL patients 658 ± 68 mL vs. GDT patients 198 ± 292 mL; P < 0.001). Overall blood consumption (intraoperatively
and postoperatively) was not different between the two groups. There were an increased number of complications
in the CTRL group (20 of 20 CTRL patients (100%) vs. 16 of 20 GDT patients (80%); P = 0.05). These outcomes were
predominantly due to a difference in minor complications (20 of 20 CTRL patients (100%) vs. 15 of 20 GDT patients
(75%); P = 0.047).
Conclusions: GDT applied during regional anaesthesia in patients undergoing elective total hip replacement
changes intraoperative fluid management and may improve patient outcomes by decreasing postoperative
complications. Larger trials are required to confirm our findings.
Trial registration: SRCTN11616985
Introduction
Total hip replacement (THR) surgery is one of the most
commonly performed major orthopaedic operations.
Because of the increasing incidence of this type of sur-
gery, a recent review article [1] considered it to be the
operation of the century. When performed in elderly
patients with comorbidities, it carries a significant bur-
den of complications and mortality, with revision sur-
gery having the highest risk (mortality up to 10%) [2-4].
Strategies that may reduce the burden of complications
are therefore warranted.
The targeted administration of intravenous fluids,
blood and vasoactive agents is commonly referred to as
goal-directed therapy (GDT). GDT has been proven to
reduce complications and mortality when performed in
many scenarios [5-10] that include hemiarthroplasty for
fractured neck of the femur [7,9]. The role of GDT in
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medium, provided the original work is properly cited.elective THR surgery and its possible impact on redu-
cing complications and mortality have not been investi-
gated to date. In recent years, the focus on postsurgical
outcomes has been mostly on reducing mortality rather
than on preventing complications. Recently, authors
have demonstrated that long-term mortality following
hospital discharge is associated with the development of
a perioperative complication. It was our view, therefore,
that strategies that decrease postoperative complications
should be sought not just in high-risk patients but also
in groups of patients who traditionally have been per-
ceived to be at lower risk of mortality but have a signifi-
cant risk of complications. We therefore decided to
study patients undergoing elective THR surgery. In addi-
tion, THR surgery is commonly performed while the
patient is under regional anaesthesia [11], which has
some purported advantages, including a reduction in
deep venous thrombosis and pulmonary embolism [12].
GDT has never been formally assessed while patients
are under regional anaesthesia. This study therefore was
undertaken to test the feasibility of applying GDT dur-
ing THR surgery in non-high-risk surgical patients
under regional anaesthesia to investigate whether GDT
w o u l dl e a dt oi m p r o v e dp a t i e n to u t c o m e s .W ea l s o
wanted to uncover the implications of spinal blockade
on intravenous fluid requirements and patients’ haemo-
dynamic status during GDT.
Materials and methods
This study was approved by the Local Research Ethics
Committee of Azienda Ospedaliero Universitaria. Adult
patients scheduled for elective total hip arthroplasty
under regional anaesthesia were screened for enrolment
into the study by a member of the research team. Exclu-
sion criteria included planned admission to a high-
dependency intensive care setting in the postoperative
period (all patients were scheduled to go back to the
general orthopaedic ward from the surgical theatres), a
contraindication to regional anaesthesia or the patient’s
refusal of consent.
Protocol
This study was a randomised, controlled, single-centre
trial conducted at the Azienda Ospedaliero Universitaria,
Udine, Italy (ISRCTN11616985). Patients were screened
for eligibility by a member of the research team who
also obtained patients’ written informed consent before
surgery. Both the patients enrolled and the clinical
teams caring for the patients were blinded to the study
arm. Patients were randomised into one of two groups
by using a concealed envelope technique: the standard
haemodynamic therapy control group (CTRL group) or
the GDT group. Patients remained in these two groups
for the duration of surgery and for a further one hour
in the postoperative recovery room. The protocol was
finished at the end of this hour, and all patients then
received standard postoperative care as directed by the
clinical teams. All patients were then discharged from
the recovery room back to the general orthopaedic ward
according to standard practise in our hospital.
All patients were sedated with 0.02 mg/kg midazolam.
Spinal anaesthesia was performed at the L3-L4 level
with 15 mg of levobupivacaine at a 0.5% concentration.
All patients underwent urinary catheterisation. Surgery
commenced after spinal anaesthesia was deemed to be
optimal. All patients received 10 mg of oxycodone two
hours before surgery and every twelve hours following
the operation for the next four days. Other analgesics
given included regular paracetamol (1 g every 6 hours)
for the first five days and tramadol and ketorolac as res-
cue analgesics when necessary.
All patients were monitored according to currently
recommended standards during the intraoperative and
immediate postoperative periods. In addition, for this
study, all patients had their arterial blood pressure mea-
sured and recorded via an indwelling radial arterial
catheter. Patients in both groups were kept normother-
mic (body temperature > 36.5°C), and the arterial oxy-
gen saturation of haemoglobin (SaO2) was maintained
above 94%. All patients received 10 mL/kg/hour of
Ringer’s lactate solution from 30 minutes prior to induc-
tion of anaesthesia through the end of surgery, when the
rate was decreased to 100 mL/hour. In addition, boluses
of 6% hydroxyethyl starch (HES) 130/0.4 (Voluven Fre-
senius Kabi, Bad Homburg, Germany) were given to the
GDT group or the CTRL group according to the study
arm to which the patient was allocated.
Control group protocol
Patients randomised to the CTRL group received the
standard therapy used at our institution prior to the
study. Ringer’s lactate solution at 10 mL/kg/hour was
started 30 minutes prior to the induction of anaesthesia.
An initial bolus of 250 mL of HES was given before the
induction of anaesthesia. Boluses of intravenous colloid
(250 mL) were administered if the patient’s mean arter-
ial pressure (MAP) fell below 65 mmHg. At the discre-
tion of the attending anaesthetist, boluses of 10 mg of
ephedrine were recommended for patients with severe
hypotension that was not responding to fluid challenges
(Figure 1).
Protocol group
Patients randomised to the GDT group were con-
nected to the FloTrac sensor/Vigileo haemodynamic
monitoring system (Edwards Lifesciences, Irvine, CA,
USA). The FloTrac sensor is the specific transducer
that is required to connect the arterial line to the
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(patient age, weight and sex), we used the pulse pres-
sure algorithm (version 1.07) to track continuously
stroke volume (SV) and cardiac output (CO). The oxy-
gen delivery index (DO2I) was then calculated by
inputting the haemoglobin concentration and SaO2
into standard equations.
The protocol for the haemodynamic management of
the GDT patients was based on the postoperative GDT
protocol of St George’s Hospital [13]. In the present
study, SV was first maximised with fluid challenges.
Boluses of 250 mL of HES were administered until the
SV failed to increase by a factor of 10%. If 25 mL/kg
HES had been given before SV maximisation was
achieved, fluid challenges were then performed with 250
mL boluses of Ringer’s lactate solution. If at this stage
the DO2I was not greater than 600 mL/m
2, then dobuta-
mine was started at a dose of 3 μg/kg/minute and
increased by the same increment every 20 minutes to
reach the described target. To ensure that dobutamine
was started only under optimal conditions, blood sam-
ples were taken every 30 minutes and blood transfusions
were used to maintain a haemoglobin concentration
over 10 g/dL (Figure 2).
Data collection and follow-up
All patients were scored for their American Society of
Anesthesiologists (ASA) classification [14] prior to
surgery. All patients were followed up until hospital dis-
charge. All complications including deaths were
recorded. These were defined ap r i o r iand were diag-
nosed by the clinical teams who were blind to study
arm allocation and were then confirmed by the research
team, We defined and classified postoperative complica-
tions according to a modified version of the Postopera-
tive Morbidity Survey used by Bennett-Guerrero et al.
[15]. The definitions of complications are described in
Additional file 1 [15,16].
Statistical analysis
The incidence of postoperative complications in this
elective population is not well known. To power the
study, we looked at differences in fluid management.
This study was therefore powered to demonstrate a dif-
ference in total intravenous fluids administered between
the two study arms. Historical data at this institution
demonstrated that in a similar cohort of patients, the
mean (± SD) total fluid administered during the opera-
tive period and for one hour in the postoperative phase
was 2,600 ± 600 mL. We estimated that a 500-mL dif-
ference in total fluid input would be relevant to the
patients, and therefore 38 patients (19 in each group)
would need to be enrolled to detect this difference with
80% power at a P value < 0.05. To allow for a 5% error
in these calculations, we set out to enrol 20 patients
into each study arm.
Figure 1 Control group fluid management. MAP = mean arterial pressure; HES = hydroxyethyl starch.
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ware (GraphPad Software, Inc., La Jolla, CA, USA). Data
are presented as means (± SD) when normally distribu-
ted and as medians (interquartile range (IQR)) when not
normally distributed. Continuous data were compared
by using either the Mann-Whitney U test or the Wil-
coxon test as appropriate. Categorical data were
compared using Fisher’s exact test. A P value < 0.05 was
considered statistically significant.
Results
F o r t yp a t i e n t sw e r ee n r o l l e di n t ot h es t u d yb e t w e e n
March 2008 and March 2009. All screened patients
were randomised, and complete follow-up was achieved
Figure 2 Intraoperative goal-directed therapy protocol (GDT). GDT = goal-directed therapy group; SV max = maximum stroke volume; DO2I
= oxygen delivery index; HES = hydroxyethyl starch; HR = heart rate; bpm = beats/minute.
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spinal anaesthesia without any complications. All
patients went back to the general ward after the end of
the operation. All patients completed the study and are
included in the intention-to-treat analysis. A consort
chart of the flow of patients is presented in Additional
file 2. The demographic characteristics and baseline hae-
modynamics of the patients are summarised in Table 1.
The two groups were similar in terms of all demo-
graphic data. In particular, the patients were well
matched for severity of illness and background comor-
bidities as assessed by their ASA scores.
Haemodynamic management
Patients randomised to the GDT group received a
greater volume of fluids during the intraoperative period
(mean (± SD) 6,032 ± 1,388 mL vs. 2,635 ± 346 mL; P <
0.0001) (Table 2). In particular, the GDT group was
given more crystalloid (mean (± SD) 3,358 ± 825 mL vs.
2,100 ± 361 mL; P < 0.0001), more colloid (mean (±
SD) 2,079 ± 858 mL vs. 535 ± 86 mL; P < 0.0001) and
more blood (mean (± SD) 595 ± 316 mL vs. 0 ± 0 mL;
P < 0.0001). The GDT patients had a higher urine out-
put (median (IQR) 1225 (650 to 1375) mL vs. 300 (100
to 475) mL; P < 0.0001) during this period and ended
up with a more positive fluid balance (3,565 ± 879 mL
vs. 1403 ± 401 mL; P < 0.0001). More patients in the
GDT group than in the CTRL group received dobuta-
mine (11 patients (55%) vs. 0 patients (0%); P < 0.0003)
(Table 2).
The patients’ baseline haemodynamics prior to induc-
tion of spinal anaesthesia were similar between the two
groups. No patient required a vasoconstrictor to main-
tain MAP, which was maintained above 65 mmHg at all
time points in both groups. On the basis of repeated
measures analysis of variance, the GDT patients had a
higher mean heart rate and a higher MAP (Figure 3)
than CTRL patients over the course of the operations.
By the end of the operations, both the mean heart rate
(78 ± 15 beats/minute vs. 63 ± 12 beats/minute; P =
0.002) and the MAP (89 ± 13 mmHg vs. 82 ± 6 mmHg;
P = 0.03) were higher in the GDT group.
At baseline in the GDT group, five patients already
had a DO2I > 600 mL/minute/m
2. During the study per-
iod, 13 (65%) of 20 patients reached a DO2I > 600 mL/
minute/m
2 in the GDT group. All but one of seven
patients who did not reach the DO2I target were started
on dobutamine therapy. The one patient was not started
on dobutamine therapy because he reached SV maximi-
sation only at the end of the study period. There were
no reported complications directly related to GDT.
Outcomes
No patients died within the 28 days of enrolment in the
study. There were no differences in time to hospital dis-
charge between the CTRL group and the GDT group
(median 10 days (IQR 9 to 11 days) vs. median 10 days
(IQR 9 or 10 days); P = 0.618).
A reduced number of patients in the GDT group
compared to the CTRL group developed postoperative
complications (16 patients (80%) vs. 20 patients (100%),
respectively; P = 0.053). The median number of compli-
cations per patient was lower in the GDT group than in
the CTRL group (median 4 complications/patient (IQR
3 to 4) vs. median 1 complication/patient (IQR 0 to 2
complications), respectively; P < 0.0001). These compli-
cations were subdivided into minor and major complica-
tions according to predefined criteria (Tables 3 and 4).
Significantly fewer patients in the GDT group than in
the CTRL group developed minor complications (15
(75%) of 20 patients vs. 20 (100%) of 20 patients, respec-
tively; relative risk (RR) 1.3 (1.04 to 1.72) and P =
0.047). Significant postoperative hypotension was espe-
cially common in the CTRL group, with 19 (95%) of 20
patients having at least one episode of systolic blood
pressure < 90 mmHg that required urgent fluid adminis-
tration (500 mL of HES) following discharge to the gen-
eral orthopaedic ward. This was a much higher
proportion than that in the GDT group (9 (45%) of 20
patients; RR 2.1 (1.3 to 3.5) and P < 0.0001). The med-
ian number of minor complications per patient was also
lower in the GDT group than in the CTRL group (1/
patient (IQR 0 to 2) vs. 4/patient (IQR 3 to 4), respec-
tively; P < 0.0001).
Five patients (25%) in the CTRL group had major
complications vs. one patient (5%) in the GDT group,
although this difference did not reach statistical signifi-
cance (p=0.076) (Table 4). No patient (0%) in the
GDT group had a major cardiac complication, while five
patients (25%) in the CTRL group did (P = 0.047).
There was a trend towards a reduction in postopera-
tive nausea and vomiting (PONV) in the GDT group
c o m p a r e dt ot h eC T R Lg r o u p( 9p a t i e n t s( 4 5 % )v s .4
patients (20%); P = 0.176), although this finding did not
reach statistical significance. Among the total number of
PONV episodes, there was a reduction in the episodes
Table 1 Demographic data and surgical characteristics of
the patients at baseline
Demographics Control GDT
Number of patients 20 20
Median age (IQR), years 63 (58 to 72) 69 (61 to 76)
Male sex, n (%) 9 (45%) 14 (70%)
Mean weight (± SD), kg 81 ± 16 80 ± 13
Median height (± SD), cm 170 (167 to 173) 170 (166 to 180)
Median ASA grade (IQR) 2 (2 to 2) 2 (2 to 2)
ASA: American Society of Anesthesiologists; GDT: goal-directed therapy.
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0.15 ± 0.1; P = 0.02; data expressed as mean (± SD)).
Discussion
This study demonstrates that GDT is feasible during
regional anaesthesia in awake patients. The protocol
that we used was associated with a significantly greater
use of intraoperative fluids and inotropic agents, with a
consequent reduction in postoperative minor complica-
tions and major cardiovascular complications. We chose
an approach similar to that used by Pearse et al. [13] in
their postoperative GDT study, in which a DO2I of 600
mL/m
2 was targeted after SV maximisation. Our proto-
col group was monitored with the Vigileo monitor. This
allowed us to give fluid in response to changes in SV
measured in real time. This is the first study in which a
SV maximisation approach was used during spinal
anaesthesia in awake patients.
Table 2 Intraoperative fluid management as well as perioperative blood consumption intraoperatively,
postoperatively and overall
Fluid management and blood transfusion CTRL group GDT group P value
Intraoperative period
Dobutamine, n (%) 0 (0%) 11 (55%) 0.0003
Dobutamine dose, μg/kg/minute n/a 4 ± 1 n.a.
Mean Crystalloids (± SD), mL 2,100 ± 361 3,358 ± 825 < 0.0001
Mean Colloids (± SD), mL 535 ± 86 2,079 ± 858 < 0.0001
Mean Blood (± SD), mL 0 595 ± 316 0.0003
Mean Total input (± SD), mL 2,635 ± 346 6,032 ± 1,388 < 0.0001
Median Urine output (IQR), mL 300 (100 to 475) 1225 (650 to 1375) < 0.0001
Median Blood loss (IQR), mL 900 (800 to 975) 900 (750 to 1200) n.s.
Mean Fluid balance (± SD), mL 1,403 ± 401 3565 ± 879 < 0.0001
Perioperative blood transfusion requirements, mL
Mean Intraoperative blood transfusion (± SD) 0 565 ± 332 0.0003
Mean Postoperative blood transfusion (± SD) 658 ± 302 198 ± 292 0.0004
Mean Total blood transfusion (± SD) 658 ± 302 792 ± 480 n/s
CTRL: control; GDT: goal-directed therapy; n/a: not applicable; n/s: not significant.
P values are reported if statistically significant.
Figure 3 Trends in heart rate and mean arterial pressure
between control group and goal-directed therapy group.H R=
heart rate; mAP = mean arterial pressure; GDT = goal-directed
therapy group; CTRL = control group.
Table 3 Minor complications during hospital stay in the
control group and the goal-directed therapy group
Minor complications CTRL, n GDT, n
Uncomplicated infections
Abdominal 1 0
Urinary 5 3
Cardiovascular
Hypotension 44 13
Anaemia
a 18 7
Total 68 23
CTRL: control; GDT; goal-directed therapy.
aanaemia requiring blood transfusion.
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administration between the GDT and CTRL groups in
this study. Our study was powered to reflect 500-mL dif-
ferences in fluid balance, while we found that the GDT
group received more than twice the fluid input of the
CTRL group. We chose to direct our CTRL group
according to local standard practise. Our CTRL patients
received a total average fluid input of 2.6 L during the
protocol period. This group, therefore, were not subject
to a ‘restricted’ approach to fluid management; in fact,
they received a considerable volume of fluid. There are
few specific data available for comparison regarding elec-
tive hip arthroplasty patients. Holte et al. [17] studied the
differences in outcomes between liberal and restrictive
strategies during elective knee arthroplasty. Patients in
the restrictive group in their study received, on average,
1.7 L of fluid in comparison to 4.2 L in the protocol arm.
Importantly, we did not want to look at a restrictive ver-
sus liberal fluid infusion strategy. In our study, we aimed
at looking at differences in individualised haemodynamic
management between two protocols.
An explanation to the high fluid intake may be that
spinal anaesthesia is responsible for relative hypovolae-
mia by abolishing the sympathetic tone, therefore creat-
ing increased venous capacitance. The biggest response
to fluid challenges in terms of increases in cardiac index
occurred just before the induction of spinal anaesthesia
and the biggest decreases occurred immediately after-
wards. The effect of spinal anaesthesia on cardiac index
has not been well described in the literature. Dyer et al.
[18] found that spinal anaesthesia was linked to a drop
in blood pressure with minimal impact on flow. Clearly,
if our results are confirmed in future studies, then the
haemodynamic impact of spinal anaesthesia is bigger
than has traditionally been expected.
GDT has been shown to be effective when applied in
high-risk surgical patients during the perioperative
period. It is often referred to as early GDT when it is
started immediately after surgery [13] or immediately
after the recognition of shock [11]. The timing of the
intervention is especially important. When started late,
after the establishment of organ failure, GDT does not
improve patient outcomes [19,20]. In the context of
high-risk surgical patients, many studies have assessed
the use of GDT intraoperatively [7-9] and demonstrated
a benefit for the patient [21,22].
To our knowledge, few studies have directly set out to
assess the effects of GDT in low-risk groups of patients.
A recent meta-analysis demonstrated, however, that
GDT is still beneficial in terms of reducing both mortal-
ity and morbidity when used in lower-risk groups [22].
Previous authors have aimed to achieve SV maximisa-
tion alone in lower-risk groups, especially during color-
ectal surgery [8,23] and following surgery for fractured
neck of the femur [7,9]. Pearse et al. [4] defined ‘high-
risk surgical patients’ as those patients who have an
expected mortality higher than 5%. GDT is traditionally
applied to this subgroup of patients. Despite this, few
studies have demonstrated a reduction in mortality. This
benefit was initially demonstrated by Shoemaker et al.
[5] and Boyd et al. [6], while more recent studies have
shown reductions in postoperative complications and
length of hospital stay [13]. Postoperative complications
may have a big impact on long-term outcomes and
affect long-term mortality even after hospital discharge
[24].
We found a large reduction in minor postoperative
complications and major cardiovascular complications.
We cannot exclude that our results may just be a reflec-
tion of monitoring variables (SV, CO and DO2I) that
normally are not monitored in this population. It is
important to remember, though, that there are several
examples in the literature where the simple use of CO
monitors (the pulmonary artery catheter, for instance)
without a protocol has not provided any benefit to the
patients [25,26]. On the other hand, a benefit has been
observed when a CO monitor has been used as part of a
preemptive strategy to optimise the haemodynamics in
surgical patients. This has recently been demonstrated
in a meta-analysis by Hamilton et al. [22]. We think
that our results are explained more by CO monitoring
and GDT than by CO monitoring alone.
Despite a reduction in total number of complications,
we did not find any reduction in hospital length of stay
or mortality. It could be argued that the lack of differ-
ences in length of stay implies that the complications
were neither serious nor relevant. The reason behind
this possibility, however, relates to the fact that all
patients in this study at our institution had a planned
length of stay of 10 days, which was not shortened even
in the absence of need. This limit on length of hospital
Table 4 Major complications during hospital stay in the
control group and the goal-directed therapy group
Major complications CTRL, n GDT, n
Infection
Pneumonia 0 0
Respiratory
Pulmonary embolism 1 1
Cardiovascular
Tachyarrhythmias
a 40
Acute coronary syndrome 2 0
Renal
Oliguria, acute renal failure 0 0
Total 8 1
CTRL: control; GDT: goal-directed therapy.
aarrhythmias requiring pharmacological interventions.
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[16,27,28].
Clearly this is important, but to demonstrate differ-
ences in either length of stay or mortality, a much larger
group of patients must be studied to provide adequate
power. Another important finding of this study has to
do with perioperative blood utilisation. The GDT group
received most of the perioperative blood during the
operation, while the CTRL group received more blood
postoperatively. Interestingly, the overall blood utilisa-
tion was the same in both groups.
Conclusions
Intraoperatively, GDT during THR surgery in which
spinal anaesthesia is used in awake patients is feasible
and leads to a different type of haemodynamic manage-
ment. Our results suggest that GDT may improve out-
comes in this population by decreasing the rate of
minor postoperative complications. Larger trials are
required to confirm our findings.
Key messages
￿ GDT during spinal anaesthesia and awake patient
is feasible using an arterial line and the Vigileo
monitor.
￿ Intraoperative GDT during THR surgery decreases
postoperative complications.
Additional material
Additional file 1: Modified Postoperative Morbidity Survey.
Classification of the complications recorded according to the modified
Postoperative Morbidity Survey (POMS). Original POMS data have been
modified to separate major and minor complications.
Additional file 2: Consort diagram of the study. Consort diagram of
patients enrolled into the study. GDT = goal-directed therapy group;
CTRL = control group.
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